Sfoglia per Autore
Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts).
2013-01-01 Cremolini, Chiara; Loupakis, F; Antoniotti, C; Fioravanti, A; Orlandi, P; Salvatore, L; Canu, B; Schirripa, M; Masi, G; DI DESIDERO, T; Marmorino, F; Bergamo, F; Zoratto, F; Bocci, Guido; Falcone, Alfredo
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.
2013-01-01 Orlandi, Paola; A., Fontana; Fioravanti, Anna; DI DESIDERO, Teresa; L., Galli; L., Derosa; B., Canu; R., Marconcini; E., Biasco; Solini, Anna; G., Francia; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration
2013-01-01 Lazzeri, S; Figus, M; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Agosta, E; Sartini, Ms; Posarelli, Chiara; Nardi, Marco; Danesi, Romano; Bocci, Guido
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1.
2013-01-01 DI DESIDERO, Teresa; Fioravanti, Anna; Orlandi, Paola; B., Canu; Giannini, Riccardo; Borrelli, Nicla; S., Man; P., Xu; Fontanini, Gabriella; Basolo, Fulvio; R. S., Kerbel; G., Francia; Danesi, Romano; Bocci, Guido
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo
2014-01-01 Antonelli, A; Bocci, G; Fallahi, P; La Motta, C; Ferrari, S; Mancusi, C; Fioravanti, A; Di Desidero, T; Sartini, S; Corti, A; Piaggi, S; Materazzi, G; Spinelli, C; Fontanini, G; Danesi, R; Da Settimo, F; Miccoli, P
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients
2014-01-01 Derosa, L; Galli, L; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Fontana, A; Antonuzzo, A; Biasco, E; Farnesi, A; Marconcini, R; Francia, G; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab.
2014-01-01 Allegrini, G; Coltelli, L; Orlandi, Paola; Fontana, A; Camerini, A; Ferro, A; Cazzaniga, M; Casadei, V; Lucchesi, S; Bona, E; Di Lieto, M; Pazzagli, I; Villa, F; Amoroso, D; Scalese, M; Arrighi, G; Molinaro, S; Fioravanti, Anna; Finale, C; Triolo, R; DI DESIDERO, Teresa; Donati, S; Marcucci, L; Goletti, Orlando; DEL RE, Marzia; Salvadori, B; Ferrarini, I; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer
2014-01-01 Cruz-Muñoz, William; Di Desidero, Teresa; Man, Shan; Xu, Ping; Jaramillo, Maria Luz; Hashimoto, Kae; Collins, Catherine; Banville, Myriam; O'Connor-Mccourt, Maureen D.; Kerbel, Robert S.
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.
2014-01-01 Bouche, G; André, N; Banavali, S; Berthold, F; Berruti, A; Bocci, Guido; Brandi, G; Cavallaro, U; Cinieri, S; Colleoni, M; Curigliano, G; DI DESIDERO, Teresa; Eniu, A; Fazio, N; Kerbel, R; Hutchinson, L; Ledzewicz, U; Munzone, E; Pasquier, E; Graciela Scharovsky, O; Shaked, Y; Stěrba, J; Villalba, M; Bertolini, F.
Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib
2015-01-01 Jedeszko, C; Paez Ribes, M; DI DESIDERO, Teresa; Man, S; Lee, Cr; Xu, P; Bjarnason, Ga; Bocci, Guido; Kerbel, Rs
High frequency ultrasound and photoacoustic imaging for tissue characterization in vivo
2015-01-01 Avigo, Cinzia; Di Lascio, Nicole; Kusmic, Claudia; Faita, Francesco; Menichetti, Luca; Armanetti, Paolo; Bocci, Guido; Di Desidero, Teresa
Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward
2015-01-01 Lazzeri, Stefano; Ripandelli, Guido; Sartini, Maria Sole; Parravano, Mariacristina; Varano, Monica; Nardi, Marco; DI DESIDERO, Teresa; Orlandi, Paola; Bocci, Guido
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients
2015-01-01 Solini, Anna; Simeon, Vittorio; Derosa, Lisa; Orlandi, Paola; Rossi, Chiara; Fontana, Andrea; Galli, Luca; DI DESIDERO, Teresa; Fioravanti, Anna; Lucchesi, Sara; Coltelli, Luigi; Ginocchi, Laura; Allegrini, Giacomo; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer
2015-01-01 DI DESIDERO, Teresa; Xu, Ping; Man, Shan; Bocci, Guido; Kerbel, Robert S.
IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration
2016-01-01 Lazzeri, Stefano; Orlandi, Paola; Piaggi, Paolo; Sartini, Maria Sole; Casini, Giamberto; Guidi, Gianluca; Figus, Michele; Fioravanti, Anna; DI DESIDERO, Teresa; Ripandelli, Guido; Parravano, Mariacristina; Varano, Monica; Nardi, Marco; Bocci, Guido
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
2016-01-01 DI DESIDERO, Teresa; Derosa, Lisa; Galli, Luca; Orlandi, Paola; Fontana, Andrea; Fioravanti, Anna; Marconcini, Riccardo; Giorgi, Mario; Campi, Beatrice; Saba, Alessandro; Lucchesi, Sara; Felipetto, Renato; Danesi, Romano; Francia, Giulio; Allegrini, Giacomo; Falcone, Alfredo; Bocci, Guido
Metronomic chemotherapy for triple negative breast cancer?
2016-01-01 DI DESIDERO, Teresa; Kerbel, Robert S; Bocci, Guido
Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
2017-01-01 Parra, Karla; Valenzuela, Paloma; Lerma, Natzidielly; Gallegos, Alejandra; Reza, Luis C; Rodriguez, Georgialina; Emmenegger, Urban; DI DESIDERO, Teresa; Bocci, Guido; Felder, Mitchell S; Manciu, Marian; Kirken, Robert A; Francia, Giulio
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World
2017-01-01 Di Paolo, Antonello; Del Re, Marzia; Arrigoni, Elena; Di Desidero, Teresa; Rofi, Eleonora; Danesi, Romano; Bocci, Guido
Prevention of capecitabine toxicity using a 5-FU test dose
2017-01-01 DI DESIDERO, Teresa; Barbara, C; Orlandi, P; Fioravanti, A; Loupakis, F; Cremolini, Chiara; Allegrini, G; DI PAOLO, Antonello; Falcone, Alfredo; Danesi, Romano; Bocci, Guido
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts). | 1-gen-2013 | Cremolini, Chiara; Loupakis, F; Antoniotti, C; Fioravanti, A; Orlandi, P; Salvatore, L; Canu, B; Schirripa, M; Masi, G; DI DESIDERO, T; Marmorino, F; Bergamo, F; Zoratto, F; Bocci, Guido; Falcone, Alfredo | |
| VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. | 1-gen-2013 | Orlandi, Paola; A., Fontana; Fioravanti, Anna; DI DESIDERO, Teresa; L., Galli; L., Derosa; B., Canu; R., Marconcini; E., Biasco; Solini, Anna; G., Francia; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration | 1-gen-2013 | Lazzeri, S; Figus, M; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Agosta, E; Sartini, Ms; Posarelli, Chiara; Nardi, Marco; Danesi, Romano; Bocci, Guido | |
| Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1. | 1-gen-2013 | DI DESIDERO, Teresa; Fioravanti, Anna; Orlandi, Paola; B., Canu; Giannini, Riccardo; Borrelli, Nicla; S., Man; P., Xu; Fontanini, Gabriella; Basolo, Fulvio; R. S., Kerbel; G., Francia; Danesi, Romano; Bocci, Guido | |
| CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo | 1-gen-2014 | Antonelli, A; Bocci, G; Fallahi, P; La Motta, C; Ferrari, S; Mancusi, C; Fioravanti, A; Di Desidero, T; Sartini, S; Corti, A; Piaggi, S; Materazzi, G; Spinelli, C; Fontanini, G; Danesi, R; Da Settimo, F; Miccoli, P | |
| Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients | 1-gen-2014 | Derosa, L; Galli, L; Orlandi, Paola; Fioravanti, Anna; DI DESIDERO, Teresa; Fontana, A; Antonuzzo, A; Biasco, E; Farnesi, A; Marconcini, R; Francia, G; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab. | 1-gen-2014 | Allegrini, G; Coltelli, L; Orlandi, Paola; Fontana, A; Camerini, A; Ferro, A; Cazzaniga, M; Casadei, V; Lucchesi, S; Bona, E; Di Lieto, M; Pazzagli, I; Villa, F; Amoroso, D; Scalese, M; Arrighi, G; Molinaro, S; Fioravanti, Anna; Finale, C; Triolo, R; DI DESIDERO, Teresa; Donati, S; Marcucci, L; Goletti, Orlando; DEL RE, Marzia; Salvadori, B; Ferrarini, I; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| Analysis of acquired resistance to metronomic oral topotecan chemotherapy plus pazopanib after prolonged preclinical potent responsiveness in advanced ovarian cancer | 1-gen-2014 | Cruz-Muñoz, William; Di Desidero, Teresa; Man, Shan; Xu, Ping; Jaramillo, Maria Luz; Hashimoto, Kae; Collins, Catherine; Banville, Myriam; O'Connor-Mccourt, Maureen D.; Kerbel, Robert S. | |
| Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan. | 1-gen-2014 | Bouche, G; André, N; Banavali, S; Berthold, F; Berruti, A; Bocci, Guido; Brandi, G; Cavallaro, U; Cinieri, S; Colleoni, M; Curigliano, G; DI DESIDERO, Teresa; Eniu, A; Fazio, N; Kerbel, R; Hutchinson, L; Ledzewicz, U; Munzone, E; Pasquier, E; Graciela Scharovsky, O; Shaked, Y; Stěrba, J; Villalba, M; Bertolini, F. | |
| Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib | 1-gen-2015 | Jedeszko, C; Paez Ribes, M; DI DESIDERO, Teresa; Man, S; Lee, Cr; Xu, P; Bjarnason, Ga; Bocci, Guido; Kerbel, Rs | |
| High frequency ultrasound and photoacoustic imaging for tissue characterization in vivo | 1-gen-2015 | Avigo, Cinzia; Di Lascio, Nicole; Kusmic, Claudia; Faita, Francesco; Menichetti, Luca; Armanetti, Paolo; Bocci, Guido; Di Desidero, Teresa | |
| Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward | 1-gen-2015 | Lazzeri, Stefano; Ripandelli, Guido; Sartini, Maria Sole; Parravano, Mariacristina; Varano, Monica; Nardi, Marco; DI DESIDERO, Teresa; Orlandi, Paola; Bocci, Guido | |
| Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients | 1-gen-2015 | Solini, Anna; Simeon, Vittorio; Derosa, Lisa; Orlandi, Paola; Rossi, Chiara; Fontana, Andrea; Galli, Luca; DI DESIDERO, Teresa; Fioravanti, Anna; Lucchesi, Sara; Coltelli, Luigi; Ginocchi, Laura; Allegrini, Giacomo; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer | 1-gen-2015 | DI DESIDERO, Teresa; Xu, Ping; Man, Shan; Bocci, Guido; Kerbel, Robert S. | |
| IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration | 1-gen-2016 | Lazzeri, Stefano; Orlandi, Paola; Piaggi, Paolo; Sartini, Maria Sole; Casini, Giamberto; Guidi, Gianluca; Figus, Michele; Fioravanti, Anna; DI DESIDERO, Teresa; Ripandelli, Guido; Parravano, Mariacristina; Varano, Monica; Nardi, Marco; Bocci, Guido | |
| Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients | 1-gen-2016 | DI DESIDERO, Teresa; Derosa, Lisa; Galli, Luca; Orlandi, Paola; Fontana, Andrea; Fioravanti, Anna; Marconcini, Riccardo; Giorgi, Mario; Campi, Beatrice; Saba, Alessandro; Lucchesi, Sara; Felipetto, Renato; Danesi, Romano; Francia, Giulio; Allegrini, Giacomo; Falcone, Alfredo; Bocci, Guido | |
| Metronomic chemotherapy for triple negative breast cancer? | 1-gen-2016 | DI DESIDERO, Teresa; Kerbel, Robert S; Bocci, Guido | |
| Impact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth | 1-gen-2017 | Parra, Karla; Valenzuela, Paloma; Lerma, Natzidielly; Gallegos, Alejandra; Reza, Luis C; Rodriguez, Georgialina; Emmenegger, Urban; DI DESIDERO, Teresa; Bocci, Guido; Felder, Mitchell S; Manciu, Marian; Kirken, Robert A; Francia, Giulio | |
| Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World | 1-gen-2017 | Di Paolo, Antonello; Del Re, Marzia; Arrigoni, Elena; Di Desidero, Teresa; Rofi, Eleonora; Danesi, Romano; Bocci, Guido | |
| Prevention of capecitabine toxicity using a 5-FU test dose | 1-gen-2017 | DI DESIDERO, Teresa; Barbara, C; Orlandi, P; Fioravanti, A; Loupakis, F; Cremolini, Chiara; Allegrini, G; DI PAOLO, Antonello; Falcone, Alfredo; Danesi, Romano; Bocci, Guido |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile